Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

United Therapeutics (UTHR) Drug Pipeline

789 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Ggta1 Ko ThymokidneyKidney Transplantation, Esrd (End-Stage Renal Disease), Xenotransplantationphase1AndPhase2RecruitingStudy to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRDNov 04, 2025―
10 Ge XenokidneyKidney Transplantation, Esrd (End-Stage Renal Disease), Xenotransplantationphase1AndPhase2RecruitingStudy to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRDMar 03, 2025
Inhaled Treprostinil, Treprostinil Ultrasonic NebulizerInterstitial Lung Disease, Progressive Pulmonary FibrosisPhase IIIRecruitingStudy of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)Jul 05, 2023
Inhaled Treprostinil, Treprostinil Ultrasonic NebulizerIdiopathic Pulmonary Fibrosis, Interstitial Lung DiseasePhase IIICompletedMultinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisFeb 15, 2022―
Oral Treprostinil, Parenteral TreprostinilPulmonary Arterial HypertensionPhase IVActive Not RecruitingA Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial HypertensionJan 10, 2022―
Inhaled Treprostinil, Treprostinil Ultrasonic NebulizerIdiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary FibrosisPhase IIIEnrolling By InvitationExtension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung DiseaseMay 20, 2021
Inhaled Treprostinil, Treprostinil Ultrasonic NebulizerIdiopathic Pulmonary Fibrosis, Interstitial Lung DiseasePhase IIICompletedStudy of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisJan 12, 2021
RalinepagCardiovascular Diseases, Hypertension, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Connective Tissue Diseases, Vascular Diseases, Lung Diseases, Pah, Hypertension, Pulmonary, Familial Primary Pulmonary Hypertension, Respiratory Tract DiseasePhase IIIEnrolling By InvitationA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionSep 19, 2018
RalinepagCardiovascular Diseases, Hypertension, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Connective Tissue Diseases, Vascular Diseases, Lung Diseases, Pah, Hypertension, Pulmonary, Familial Primary Pulmonary Hypertension, Respiratory Tract DiseasePhase IIICompletedA Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH PatientsJul 27, 2018
Oral TreprostinilPahPhase IICompletedSafety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 YearsOct 21, 2014―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does United Therapeutics Corp. (UTHR) have in its pipeline
United Therapeutics UTHR is currently developing the following drugs: Ggta1 Ko Thymokidney, 10 Ge Xenokidney, Inhaled Treprostinil, Treprostinil Ultrasonic Nebulizer, Oral Treprostinil, Parenteral Treprostinil, Ralinepag, Oral Treprostinil. These drug candidates are in various stages of clinical development as the company works toward FDA approval.